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Abstract
Patients suffering from dementia of Alzheimer’s type express less serotonin 4 receptors (5-HTR4), but whether an absence of
these receptors modifies learning and memory is unexplored. In the spatial version of the Morris water maze, we show that
5-HTR4 knock-out (KO) and wild-type (WT) mice performed similarly for spatial learning, short- and long-term retention.
Since 5-HTR4 control mnesic abilities, we tested whether cholinergic system had circumvented the absence of 5-HTR4.
Inactivating muscarinic receptor with scopolamine, at an ineffective dose (0.8 mg/kg) to alter memory in WT mice,
decreased long-term but not short-term memory of 5-HTR4 KO mice. Other changes included decreases in the activity of
choline acetyltransferase (ChAT), the required enzyme for acetylcholine synthesis, in the septum and the dorsal
hippocampus in 5-HTR4 KO under baseline conditions. Training- and scopolamine-induced increase and decrease,
respectively in ChAT activity in the septum in WT mice were not detected in the 5-HTR4 KO animals. Findings suggest that
adaptive changes in cholinergic systems may circumvent the absence of 5-HTR4 to maintain long-term memory under
baseline conditions. In contrast, despite adaptive mechanisms, the absence of 5-HTR4 aggravates scopolamine-induced
memory impairments. The mechanisms whereby 5-HTR4 mediate a tonic influence on ChAT activity and muscarinic
receptors remain to be determined.
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Introduction
Serotonin (5-hydroxytryptamine 5-HT) modulates learning and
memory, as reported by several pharmacological studies aimed at
define the specific involvement of 5-HT receptors in these processes
[1]. The administration of 5-HT2A/2C or 5-HT4 receptor (5-HTR4)
agonists or 5-HT1A or 5-HT3 and 5-HT1B receptor antagonists
prevents memory impairment and facilitates learning in situations
involving a high cognitive demand [1].
Despite largeeffortstofind outhow totreat memoryandlearning
impairments, treatment remained either in part or in whole
ineffective. Among the eighteen 5-HT receptors, the 5-HTR4 has
been itemized as an attractive target [2]. Numerous studies argued
that 5-HTR4 contribute to regulate learning and memory. The
systemic injection of the 5-HTR4 partial agonist RS 67333
produced increases in place and object recognition following
systemic injections in both young and old rats during the acquisition
phase [3,4]. Furthermore, injecting RS 67333 during the
consolidation phase enhancedobject and placerecognition memory
only in old rats [3]. In a similar behavioral paradigm, a weak dose of
SL 650155, another 5-HTR4 partial agonist, improved memoriza-
tion [5]. Activating 5-HTR4 could thus attenuate memory deficits
that installed gradually over time during development. Using these
behavioral paradigms, 5-HTR4 antagonists (GR 125487, SDZ
205557) induced no change by themselves, butblocked the effects of
RS 67333 and SL 650155, respectively [3,5]. SL 650155 has further
been found to suppress cognitive deficits of old rats using the linear
maze test, as well as scopolamine-induced deficits in Morris water
maze performances [5]. Moreover, SL 650155 and the cholines-
terase inhibitor rivastigmine have a synergistic effect in old rat
performances in the object recognition test and in the linear maze
[5]. This synergism is interesting in view of a co-treatment of
patients suffering from Alzheimer’s disease because reduce the dose
ofcholinesterase inhibitors maydecrease theirside effects. Similarly,
galanthaminium, a new cholinesterase inhibitor combined to a
partial 5-HTR4 agonist (RS 67333), enhances place and object
recognition performances in young and old rats [6].
The hippocampus is a key cerebral center involved in learning
and memory [7,8,9,10]. In the hippocampus, electrophysiological
studies have described that CA1 neurons [11,12,13,14] and
granule cells in the dentate gyrus express 5-HTR4 [15]. In the
prefrontal cortex (PFC), 60% of glutamatergic pyramidal neurons,
express 5-HTR4 as determined by electrophysiological responses
[16] and single cell PCR [17]. Numerous studies indicate that
activating 5-HTR4 increases the release of acetylcholine (ACh) in
both the cerebral cortex [18] and the hippocampus [14].
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not been explored yet. We thus tested the performances of the 5-
HTR4 KO mice in different behavioral paradigms that are mainly
targeted toward the analyses of spatial behavior and memory. The
present studies clearly indicate that the genetic ablation of 5-HTR4
did not alter learning and memory capacities in mice. In contrast,
the deleterious effect of scopolamine, a cholinergic antagonist, on
long term memory, was enhanced in mice lacking 5-HTR4. Other
changes included decreases in the activity of the ACh synthesis
enzyme, choline acetyl transferase (ChAT), in the PFC and
septum, but not in the dorsal hippocampus in the 5-HTR4 KO in
baseline conditions. ChAT activity was then studied following
training and scopolamine treatment in mice of both genotypes.
Materials and Methods
Animals
The subjects were male 129/SvTer wild type (WT) and
homozygous 5-HTR4 KO mice (generation detailed by Compan
et al., 2004 [19]), obtained from heterozygous breeding. Mice were
housed individually in standard transparent laboratory cages
(26612614 cm) in a temperature-controlled (2261uC) colony
room, adjacent to the experimental room. Mice were provided
with food and water available ad libitum and maintained on a 12:12
light/dark artificial cycle (lights on at 6:00 h). Mice were tested over
the light phase between 10:00 and 17:00 h. At the beginning of the
behavioral experiments the subjects (n=16 in each genotype) were
4–5 months old. One week before the beginning of the experiments,
mice were handled and weighed eachday by the experimenter. The
genotype of each mouse was systematically controlled before each
experiment. We performed experiments with different groups of
WT and KO mice in accordance with the Guide for Care and Use of
Laboratory Animals established by the Centre National de la
Recherche Scientifique. All experiments were carried out according
to ethical committee guidelines (Comite ´r e ´gional d’e ´thique de
Montpellier, project agreement nuC34-172-13; animal experiment
authorization nu 21CAE011).
Locomotor Activity
The protocol used was adapted from Malleret et al. (1999) [20].
Locomotor activity was assessed using activity cages, where the
mouse can move inside a cylindrical corridor. Eight photobeam
cells connected to a computer that records the activity defined as
the number of revolutions per min made by the subject. The mice
were tested for 60 min on a single test day. One measure was
taken every 5 min.
Spontaneous Alternation
The Y-maze consisted of three identical arms (34610618 cm)
converging at the center of a triangular area. A symmetrical Y
shape was thus formed (120uC of angular deviation form each
other). The apparatus was placed on the floor of the experimental
room and the behavior of the mice was recorded using a video
camera hung above it. Mice were placed individually in the central
area to explore the maze freely for 6 min. The sequence of arms
visited was recorded. Global activity was evaluated using the
number of visits into the different arms. Alternation (vs. repetition)
was defined as a visit to one arm followed by a visit to another
arm. The frequency of spontaneous alternation was calculated as
the ratio of actual alternation/possible maximum alternations.
Elevated Plus Maze
This test was used to assess anxiety-like behavior in WT and
5-HTR4 KO mice to determine possible interfering emotional
factors that may modulate performance in learning and memory
tasks [21]. As described [20], the plus maze was made of four, dark
gray Plexiglas arms, two open arms (6767 cm) and two closed
arms (6767617 cm) that formed a cross shape with the two open
arms opposite each other. The maze was set at 55 cm above the
floor and dimly illuminated (20 lux). Photobeam cells (connected
to a computer), placed at two different levels along length of each
arm, allowed detection of the passage of the animal from the
central platform (767 cm) to any arm, and from the middle of an
arm to its extremity (and return). Mice were placed individually on
the central platform, facing an open arm and were allowed to
explore the apparatus for 8 min. The number of entries into the
four arms is related to global activity. The level of anxiety-like
behavior in mice was evaluated by the relative number of entries
or time spent in the open vs. closed arms (open arms/open +
enclosed arms).
Spatial Learning in a Water Maze
The apparatus was a white circular swimming pool (diameter:
140 cm, walls: 40 cm high), which was located in a room with
various distal cues. The pool was filled with water (depth: 30 cm)
maintained at 20uC, which was made opaque by the addition of a
nontoxic white paint. Inside the pool was a removable circular
platform in plexiglas (diameter: 13 cm) positioned such that its top
surface was positioned at 0.5 cm below the water surface. The
platform served as a refuge from the water and was generally
located in the center of an arbitrarily defined quadrant of the
maze. Data were collected using a video camera fixed to the
ceiling and connected to a videotracking system (Videotrack
Viewpoint, Lyon, France) and to a video recorder, both located in
an adjacent room that received the individual home cages of mice
currently tested.
Each mouse received a pretraining session that consisted in
placing the mouse on the platform where it had to stay at least
15 s, followed by a 30 s swimming period, and ended by several
trials of climbing onto the platform until each subject was able to
climb without help. This non spatial procedure was required to
avoid confusion between procedural aspects of the task and
subsequent spatial performance [22].
During the learning stages proper (training), each animal was
subjected to a daily four-trial session. Before the first trial of the
first session, only, the mouse was placed for 15 s on the platform.
Each trial consisted of releasing the mouse into the water facing
the outer edge of the pool at one of the quadrants (except the
quadrant where the platform was located) and letting the animal
swim to escape to the platform before 90 s had elapsed. A trial
terminated when the animal reached the platform, where it
remained for 15 s. Mice that failed to find the platform within this
time limit were invited to follow the finger of the experimenter
which indicated the location of the platform, and had to stay onto
the platform for 15 s before being removed and placed back in
their home cage for a 15 min inter-trial interval. The cages were
placed beneath a heat lamp to reduce core temperature loss. The
releasing point differed at each trial (for example east, west, south
and east if the platform was in the north quadrant), and different
sequences of releasing points were used from day to day. The mice
run by squads of eight, i.e., they had their first trial successively,
then their second, until the fourth and last one; WT and 5-HTR4
KO mice ran alternately. At different stages of learning, animals
were generally given a probe trial, which consisted of letting the
mouse swim in the pool for a fixed duration (60 s), while the
platform was removed. The releasing point was in the quadrant
opposite to that where the platform was previously located.
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parameters of the performance of mice: 1) escape latency, i.e. the
time required to escape to the platform from the releasing point (in
seconds, s), and 2) path length, i.e. the distance covered by the
mouse until it reaches the platform (in centimeters, cm), a measure
of accuracy, as described [20]. Mean swim speed (path length/
latency, in centimeters/second, cm/s) was also calculated.
Firstly, sixteen naive WT and 5-HTR4 KO mice were tested
(water maze: experiment 1). On the first day, following the
procedural pre-training, each mouse performed a visually guided
orientation session, i.e., a series of four trials for which the
submerged platform had a visible white cylinder (diameter: 4 cm,
height: 7 cm) on the top, and was placed in a new location from
trial to trial. Spatial learning proper started the day after (day 2)
with the hidden platform alone, placed in a fixed location, to
evaluate spatial reference memory performances. It was composed
of two main stages: (1) acquisition (9 days, days 2–10), with the
escape platform located in the center of the north quadrant; (2)
reversal (4 days, days 11–14), with the platform located in the
center of the east quadrant. On days 5 (mid-time acquisition), 10
(end of acquisition), and 14 (end of reversal), the mouse was given
a fifth trial, which was a probe trial. A single (probe) trial was also
conducted on day 15 (i.e. 24 h after the end of reversal), and
finally on day 20 (i.e. 6 days after the end of reversal).
Secondly, when they were eight months old, the same mice were
re-evaluated in the same experiment, using the same material and
methods in a new laboratory environment (water maze: experi-
ment 2). No significant differences were observed between the
results of the original learning and its replicate. We thus used the
following procedure. The mice performed a four-day spatial
learning and half mice of both genotypes received an injection of
scopolamine, a muscarinic cholinergic antagonist (0.8 mg/kg, i.p.,
n=8 WT-Sco and n=8 KO-Sco) or saline (n=8, WT-Sal and
n=8 KO-Sal) 20 min before the first daily trial. The order of
testing was counterbalanced between genotype and treatment. On
the fourth and last day of learning, mice were given a fifth trial,
which was a probe trial. A single (probe) trial was also conducted
on the day after (day 5, i.e. 24 h later), but the mice were not
injected on that day.
ChAT Assay
Animals of both genotypes were sacrificed in basal condition and
after the various treatments used and the prefrontal cortex (PFC:
1.2 mm
3), the septum (3.9 mm
3) and dorsal hippocampus
(1.2 mm
3) were microdissected from 1 mm-thick sections at
220uC using a micropunch following the landmarks of the
stereotaxic atlas (PFC: A +1.6 mm, septum: 0.90 mm, dorsal
hippocampus: A 21.70 mm, from bregma, see [23]. ChAT activity
was measured as described by Santamaria et al. (2009) [24] using
[
3H]acetylcoenzyme A (4.4 Ci/mmol; Amersham, Arlington
Heights, IL) as a substrate. Each assay was done in duplicate.
Proteins were determined by the method of Bradford (1976) using
bovine serum albumin as standard. ChAT specific activity is
expressed as pmol ACh/min/mg proteins.
Statistical Analyses
Behavioral study. The data of 1) locomotor activity (activity
cage), 2) spontaneous alternation (Y maze) and 3) anxiety (elevated
plus maze), were statistically evaluated using ANOVAs (StatView
5.1, SAS Institute) with the genotype (WT, KO) as the between-
subject factor and respectively; 1) the number of revolutions, 2) the
number of visits to different arms and the ratio of alternations, 3)
the number of entries into arms and entries in open/(open +
enclosed arms) as within-subject factors. The data related to the
water maze experiments used the genotype (WT, KO; experiment
1 and 2) and treatment (Sco, Sal; experiment 2) as the between-
subject factors. Trial, day, zones were the main within-subject
factors of the analyses of variance (using StatView 5.01, SAS
Institute Inc.). When the effect of main factors was significant
(p,0.05), the Scheffe ´ F test (p,0.05) was used for post-hoc
analyses of individual group comparisons.
For the visually-guided orientation task, performance
was evaluated across trials. For the spatial reference memory
learning, performance was evaluated over days (averaged over the
four training trials). We analyzed separately the acquisition (days
2–10) and reversal (days 11–14) stages for experiment 1. For the
analyses of probe trials, we used 1) the path length in the whole
swimming pool, assessing swim speed (probe trials have a fixed
duration), 2) the relative path length in the target quadrant/path
length in the whole pool (TargetQ/TotQs), and 3) the relative
path length in the target platform zone/path length in the four
equivalent zones (TargetPF/TotPs). These ratios, applied to each
experimental group, allowed to determine a chance level (.25) for
visiting the target quadrant zone or the platform zone, and to
evaluate statistically (using a Student’s t - test) whether swimming
in the target quadrant or platform represents a spatial selectivity,
which is significantly different from chance level.
Biochemical studies. For these analyses, genotype and
treatment were used as independent variables. Parameters from
biochemistry were used as dependant variables. If significant
effects of genotype or genotype x treatment interaction were
found, the independent variables were split for a one-way
ANOVA (genotype or treatment) analysis. For multiple
comparisons, we used the Scheffe ´ F test with a probability of
0.01 and 0.05 as a significant difference.
Results
Locomotor Activity
Locomotor activity decreased regularly over time (5 min
blocks/60 min test) in both WT and 5-HTR4 KO mice
(F(11,330)=142.78, p,0.0001). The ANOVA revealed no signifi-
cant effect of genotype or genotype x time interaction, which
indicates equivalent abilities of habituation in a new environment
and equivalent basal level of locomotion. However, over the first
5 min of the test session, ANOVA revealed a genotype effect
(F(1,30)=7.08, p=0.01) based on a lower level of activity in KO
compared to WT mice (not illustrated), as similarly reported [19].
Over the next following 55 min, the activity of 5-HTR4 KO and
WT was identical.
Spontaneous Alternation in the Y Maze
The number of visits in the arms was weaker in 5-HTR4 KO
than WT animals (F(1,30)=8.07, p=0.008), suggesting a decreased
exploratory activity (not shown). However, the mutant mice
exhibited equivalent levels of spontaneous alternation compared to
WT mice (around 87%). No significant (F,1) genotype effect was
found for this measure of basic working memory ability.
Anxiety-Related Behavior
Anxiety-related behavior of 5-HTR4 KO mice was examined
using the elevated plus maze. No differences between mice of both
genotypes were detected in the global activity or the anxiety-
related parameters (all Fs,1, not shown).
Spatial Learning in a Water Maze (Experiment 1)
Over the visually-guided orientation task (day 1), mice learned
to orient themselves towards a cued platform through four
Long-Term Memory and 5-HTR4
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mice of both genotypes for either escape latency and path length
(both Fs,1). The KO and WT mice did not further differ in swim
speed [F,1]. A significant trial effect for the escape latency
[F(3,90)=11.19, p,0.0001] and path length [F(3,90)=7.36,
p=0.0002] was associated with a decrease of these parameters
across the four trials. The ability of 5-HTR4 KO and WT mice to
acquire the cued version of the water maze task was then identical,
suggesting that the sensori-motor capacities and motivation were
not modified in the absence of 5-HTR4.
Over days 2–10 (acquisition: spatial reference memory
learning), the swim speed of the WT and KO mice was identical
[F,1]. A progressive decrease in escape latency and path length
over days was observed, indicating that mice of both genotypes
learned the task. A significant day effect was found for the latency
[F(8,240)=37.65, p,0.0001] and path length [F(8,240)=41.65,
p,0.0001] (Fig. 1A, left-hand side). The 5-HTR4 KO and WT
mice exhibited similar patterns of performance over time
(interaction day x genotype [both Fs,1]). The swim speed of
WT and KO mice was further decreased over time (day effect,
F(8, 240)=29.78; p,0.0001). In summary, the performances of WT
and KO mice did not differ in the water maze. The spatial
reference memory is therefore not altered in the absence of
5-HTR4.
Over days 11–14 (reversal days: spatial reference memory
learning), the displacement of the platform (see day 11, first day of
reversal) increased the mean escape latency and path length in the
same extent in both the WT and 5-HTR4 KO mice, which started
at an identical level of performance (Fig. 1A). This deficit
was compensated across subsequent days. Hence, mice lacking
or not the 5-HTR4 acquired the new goal location over days
11–14 (escape latency: F(3, 90)=32.11, p,0.0001; path length:
F(3, 90)=24.32, p,0.0001) with no significant differences between
genotypes and no interaction effects (all Fs,1). For this period of
time, swim speed was not significantly modified over days [F,1].
Over the probe trials (on days 5, 10, 14, 15 and 20), the absence
of 5-HTR4 did not significantly affect swim speed. Globally, mice
exhibited significant spatial selectivity (above chance level) when
considering the target quadrant or the target platform zone
(Fig. 1B). The spatial selectivity for the target quadrant did not
differ between mice of both genotypes over probe trials (all Fs,1).
5-HTR4 KO mice exhibited significant spatial selectivity (i.e.
above chance level), on all probe trials (day 5, t(15)=3.66,
p=0.002; day 10, t(15)=7.16, p,0.0001; day 14, t(15)=6.26,
p,0.0001; day 15, t(15)=3.50, p=0.003; day 20, t(15)=2.12,
p=0.05), as well as WT mice (day 5, t(15)=4.07, p=0.001; day 10,
t(15)=6.69, p,0.0001; day 14, t(15)=4.99, p=0.0002; day 15,
t(15)=3.82, p=0.002; day 20, t(15)=2.80, p=0.01). The analysis
of spatial selectivity for the target platform did not reveal any
significant effect of genotype for each probe trial (ps.0.05). The
selective remembering of the target platform position was clearly
exhibited, as for the quadrant zones, in WT mice (day 5,
t(15)=4.35, p=0.0006; day 10, t(15)=6.56, p,0.0001; day 14,
t(15)=5.83, p,0.0001; day 15, t(15)=3.79, p=0.002; day 20,
t(15)=2.42, p=0.03). It was different in 5-HTR4 KO mice, which
showed a deficit in spatial retrieval shortly during the acquisition
stage (day 5) and later when tested for long-term memory (day 20)
(day 5, t(15)=1.60, p=0.13; day 10, t(15)=8.81, p,0.0001; day 14,
t(15)=5.11, p=0.0001; day 15, t(15)=3.89, p=0.001; day 20,
t(15)=1.57, p=0.14).
Spatial Learning in a Water Maze Following Scopolamine
(Experiment 2)
Over days 1–4 (acquisition), no significant genotype or treatment
effect was observed for swim speed [Fs,1]. A progressive decrease
in escape latency and path length across the four days was globally
Figure 1. Spatial learning and reference memory of the 5-HTR4 knock-out mice (experiment 1). Left-hand side (A): Performance over days
(2–14) for the acquisition (days 2–10) and the reversal (days 11–14) of spatial memory testing in the Morris water maze for wild-type (WT) and 5-HTR4
knock-out (KO) mice. The score on each day represents the mean 6 s.e. of path length (cm). Right-hand side (B): Probe trials (60 s) on days 5, 10, 14,
15, and 20. Mean 6 s.e. path length in the target platform zone/sum of path lengths in the four equivalent zones (target PF/totPFs) in WT and KO
mice. Horizontal lines represent chance level.
doi:10.1371/journal.pone.0009529.g001
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significant day effects for the latency [F(3,84)=5.32, p=0.002] and
path length [F(3,84)=8.98, p,0.0001]. The effect of treatment
was significant [latency: F(1,28)=7.33, p=0.01; path length:
F(1,28)=4.86, p=0.036], but not the effect of genotype, or the
interaction treatment x genotype [all Fs,1]. Interestingly, the effect
of treatment affected 5-HTR4 KO mice [latency: F(1,14)=6.10,
p=0.027; path length: F(1,14)=5.98, p=0.028], not WT mice
[latency: F(1,14)=1.87, p=0.19; path length: F,1]. This suggests
that 5-HTR4 KO mice reactedto thetreatment ata dose,whichdid
not significantly alter the performance of WT mice, at least over the
acquisition of this familiar task. The performances on the last day of
thelearningtest session(day4)werenolongerdifferentbetween any
treatments and genotypes (both Fs,1). The swim speed was,
otherwise, characterized by a progressive decrease over days
[F(3,84)=26.20, p,0.0001], in a similar extent in mice of both
genotypes or following any treatment (both Fs,1).
On day 4 (probe trial), mice were tested immediately after the
four daily training trials, i.e. remain under the influence of the
treatment, but at that time the effect of the treatment on indices of
performance was found ineffective (see supra). ANOVA conducted
on swim speed revealed no significant effects of genotype and
treatment, but a significant genotype x treatment interaction
[F(1,28)=5.41, p=0.03]. This was due to scopolamine-treated 5-
HTR4 KO mice that exhibited increased swim speed [drug effect:
F(1,14)=4.67, p=0.05] while WT mice did not [F,1]; (Fig. 2B,
right-hand side). Globally, mice exhibited weak spatial selectivity
as considering the target quadrant, or the target platform zone. No
significant genotype, treatment or, genotype x treatment interac-
tions were observed (all ps.0.05). The selectivity for the target
quadrant was exhibited by WT-Sal (t(7)=3.36, p=0.01), but not
by WT-Sco (t(7)=1.7, p=0.13), KO-Sal (t(7)=1.4, p=0.20), and
KO-Sco (t(7)=20.4, p=0.70). The same pattern of results was
obtained considering spatial selectivity for the target platform
zone, where it was significant in WT-Sal (t(7)=2.97, p=0.02), but
not in WT-Sco (t(7)=1.03, p=0.34), KO-Sal (t(7)=1.37, p=0.21),
and KO-Sco (t(7)=22.04, p=0.08).
On day 5 (probe trial), when tested 24 h later, without previous
training or treatment, 5-HTR4KO mice no longer exhibited increased
in swim speed as related to their treatment on the day(s) before (Fig. 2B,
right-hand side). ANOVA analyses of swim speed revealed no
significant effects of genotype, treatment, and of the interaction
genotype x treatment (all ps.0.05). Whatever their genotype and
treatment, mice did not exhibit a significant spatial selectivity for the
target quadrant (WT-Sal, t(7)=20.42, p=0.68; WT-Sco, t(7)=0.20,
p=0.85;KO-Sal,t (7)=0.97, p=0.36; KO-Sco, t(7)=21.74, p=0.12).
The pattern of results was different regarding selectivity toward the
platform zone. ANOVA revealed no significant genotype effect (F,1),
but a significant effect of treatment [F(1,28)=4.81, p=0.04], which
concerned 5-HTR4 KO [F(1,14)=7.32, p=0.02], not of WT (F,1)
mice. WT-Sal exhibited above chance-level preference above
chance level (t(7)=3.30, p=0.01), but not WT-Sco (t(7)=1.02,
p=0.34), KO-Sal (t(7)=2.06, p=0.08), and KO-Sco (t(7)=21.93,
p=0.09).
In summary, results reveal that in a spatial version of the Morris
water maze, learning, short- and long-term memories are not
affected in the absence of 5-HTR4. In contrast, the deleterious
effect of scopolamine on long-term memory performances was
aggravated in the 5-HTR4 KO compared to WT animals. Since
previous studies have reported that stimulating 5-HTR4 increases
the levels of extracellular ACh in the frontal cortex [25], we set
out, even if it was not the primary focus of our study, to test
Figure 2. Spatial learning and reference memory of the 5-HTR4 knock-out mice (experiment 2). Effect of scopolamine injection (0.8 mg/
kg, i.p., 20 min) on performance. Left-hand side (A): mean 6 s.e. of path length (cm) over days (1–4) in wild type (WT) and 5-HTR4 knock-out (KO)
mice. Right-hand side (B): Probe trials (60 s) on days 4 and 5. Top: Mean 6 s.e. path length in the whole pool (swim speed) of the WT and KO mice.
Bottom: Mean 6 s.e. path length in the target platform zone/sum of path lengths in the four equivalent zones (target PF/totPFs) in WT and KO mice.
Horizontal lines represent chance level. A significant treatment effect is noted (* p=0.05, ** p=0.02).
doi:10.1371/journal.pone.0009529.g002
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in selected brain areas under basal conditions and following the
behavioral training tests.
Adaptive Changes in ChAT Activity in 5-HTR4 KO Mice
Inbaselineconditions,theenzymaticactivityofChATwasslightly
decreasedinthedorsalhippocampus(218%,F(1,12)=5.46,p,0.05),
and even more reduced in the septum (233%, F(1,12)=11.24,
p,0.01) but not in the PFC in 5-HTR4 KO compared to WT mice
(F(1,12)=0.14, Fig. 3).
Following the behavioral tests (training session), the enzymatic
activity of ChAT was markedly higher in the septum in WT mice
compared to naive WT animals (+81%, F(1,9)=18.75, p,0.01;
Fig. 3). No significant differences were detected in the septum
between mutant mice under post-training and baseline conditions
(interaction genotype x conditions: F1,16=7.75; p,0.05). The
enzymatic activity of ChAT was decreased in the PFC (235%,
F(1,8)=37.08, p,0.01), but unchanged in the dorsal hippocampus
(F(1,9)=0.25) in trained WT compared to naive WT mice. Similar
changes were also observed in both the PFC (248%, F(1,9)=18.70,
p,0.01) and in the dorsal hippocampus (F(1,9)=0.22) in trained
5-HTR4 KO compared to naive mutant mice (Fig. 3).
The activity of ChAT was considerably decreased in the septum
(260%, F(1,7)=20.94, p,0.01) and in the PFC (226%,
F(1,5)=7.56, p,0.01) in scopolamine-treated and trained WT
compared to saline-treated and trained WT mice (Fig. 4). These
both changes were not observed in 5-HTR4 KO mice (septum:
F(1,5)=0.05, PFC: PFC: F(1,5)=3.20 with significant genotype x
treatment interaction, septum: F(1,12)=9.54, p,0.01; PFC:
F(1,10)=8.84, p,0.05).
It was unchanged in the dorsal hippocampus in scopolamine-
treated and trained WT compared to saline-treated and trained
WT as well as KO mice (Fig. 4).
Discussion
Findings clearly indicate that the null mutation of the mHtr4
gene did not induce learning and memory impairments. The
memory performances of mutant mice were markedly decreased
only following the administration of anticholinergic antagonist,
scopolamine. It suggests that the muscarinic receptor function is
enhanced in the absence of 5-HTR4, which has circumvented the
loss-of-function mutation and maintained long-term memory
performances, in baseline conditions. Unfortunately, the musca-
rinic function appears limited in its ability to adapt, reaching a
‘‘threshold limit’’, because the deleterious effect of scopolamine on
long-term memory was aggravated in the absence of 5-HTR4. The
hyperfunction of muscarinic receptors may further contribute to
compensate the decreased activity of ChAT detected in the 5-
HTR4 KO mice, providing the additional first evidence that 5-
HTR4 exert a tonic and positive control of the enzymatic activity
of ChAT.
Over the last two decades, numerous studies have proposed that
5-HTR4 may contribute to learning and memory [26]. 5-HTR4
are located in cerebral structures, long known to influence
memory, such as the hippocampus and the medial PFC
[12,14,17,27,28]. In general, stimulating 5-HTR4 facilitates
memory. For instance, injection of 5-HTR4 agonists enhances
acquisition and performance of spatial learning [29,30,31,32]. The
5-HTR4 antagonist decreases olfactory-associated memory [33].
In contrast, the present study indicates that learning and the
spatial memory were not affected in 5-HTR4 KO mice. Using
both the water and Y mazes, we further found that working (short-
term) and long-term memory was unchanged in the absence of 5-
HTR4. Results clearly suggest that learning and memory abilities
are not altered when the mHtr4 gene encoding 5-HTR4 is
disrupted, as far as the mutant mice are maintained in baseline
conditions.
Results from pharmacological and present studies are not
necessarily in discordance. It is often suggested that adaptive
changes in neurons following the null mutation of any gene may
occur over time during development, which may circumvent the
loss-of-function mutation [34]. We have recently described that 5-
HTR4 KO mice displayed a number of adaptive changes in
serotoninergic neurons of the raphe nuclei [35]. In contrast, no
major change was detected in 5-HT territories of projection, with
however few exceptions [35].
These include a decreased density of 5-HTR1A sites in the
dorsal hippocampus (CA1) and in the septum in 5-HTR4 KO
mice, in baseline condition [35]. Such reductions may likely
contribute to maintain the level of performance of 5-HTR4 KO
mice because 5-HTR1A exerts an opposite effect on memory
components, as reviewed [1]. Stimulating 5-HTR1A impairs
memory [36,37,38,39,40,41,42]. For instance, injecting 5-HTR1A
Figure 3. Reduced enzymatic activity of ChAT in the absence of 5-HTR4. Values are means 6 s.e.m. of ChAT activity expressed in pmol ACh/
min/mg protein for 7–8 WT and 6–7 KO mice in baseline conditions and 3–4 WT and 3–4 KO mice following the session of behavioral tests. A
significant difference between genotypes or conditions is marked (* p,0.05, ** p,0.01 and 11 p,0.01, 111 p,0.001, respectively). The genotype x
condition interaction is significant (# p,0.05).
doi:10.1371/journal.pone.0009529.g003
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memory [36,38]. Recent work by Topic and colleagues [43] have
further demonstrated that increased 5-HTR1A binding in the
hippocampus is associated with a decline in spatial memory of rats.
Likewise, a transient overexpression of 5-HTR1A during embry-
onic and perinatal development has detrimental effects on water-
maze performance at adult stages [44]. In 5-HTR1A KO mice the
fear response to contextual clues increases [45]. Due to decreased
5-HTR1A binding in their dorsal hippocampus, responses to
learned fear in 5-HTR4 KO mice should be interesting to explore.
The present study indicates that cholinergic system function
further adapts in the absence of 5-HTR4. The chronic blockade of
muscarinic receptors revealed impairments in the long-term
retentionin5-HTR4 KOmice foranineffectivedoseofscopolamine
in WT animals. Results accord those of Lelong and colleagues
indicating that the injection of the BIMU1 and the 5-HTR4 partial
agonist (RS 67333) prevented the deleterious mnemonic effects of
scopolamine, using the Y-maze [32]. Likewise, stimulating 5-HTR4
with the intracerebroventricular injection of SC 53116 reduced the
negative effects of scopolamine in the passive avoidance task [14].
Previous studies indicate that stimulating 5-HTR4 increases ACh
release in both the frontal cortex and the hippocampus [14,25,46].
The present study provides a new evidence that 5-HTR4 mediates a
tonic and excitatory influence on the enzymatic activity of ChAT in
both the dorsal hippocampus and septum, but not in the PFC, in
baseline conditions.It raises the question of the origin of this influence
on cholinergic transmission. The regional and cellular distribution
of 5-HTR4 has been extensively described in the brain of rodent,
using selective radioligands [47,48], combined with lesion or
molecular studies [19,49,50]. Autoradiographic studies have shown
high densities of 5-HTR4 in the rat hippocampus, using both the
radiolabeled antagonists [
3H]GR113808 [47] or [
125I]SB207710
[48]. In the hippocampus, 5-HTR4 appear localized on both the
somatodendritic and axonal zones of neurons from dentate granule
cells to field CA3 and mainly on the soma of CA1 pyramidal cells
[48]. Whether or not cholinergic neurons may express 5-HTR4
remained unknown. Beyond, results are in accordance with the
ability of prucalopride (a 5-HTR4 agonist) combined with donepezil
(an acetylcholinesterase inhibitor) to suppress scopolamine-induced
amnesia [51].
The present study evidences that the genetic ablation of 5-
HTR4 did not impair learning and memory under baseline
conditions because of an adapted cholinergic hyperfunction, which
however cannot totally overcome the absence of 5-HTR4.
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